Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis - Mercer, L K; Lunt, M; Low, A L (Ann Rheum Dis, 2015)
et al.